Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cetuximab, a chimeric mouse-human IgG1 monoclonal antibody against the epidermal growth factor receptor, is approved for use in colorectal cancer and squamous-cell carcinoma of the head and neck. A high prevalence of hypersensitivity reactions to cetuximab has been reported in some areas of the United States. METHODS: We analyzed serum samples from four groups of subjects for IgE antibodies against cetuximab: pretreatment samples from 76 case subjects who had been treated with cetuximab at multiple centers, predominantly in Tennessee, Arkansas, and North Carolina; samples from 72 control subjects in Tennessee; samples from 49 control subjects with cancer in northern California; and samples from 341 female control subjects in Boston. RESULTS: Among 76 cetuximab-treated subjects, 25 had a hypersensitivity reaction to the drug. IgE antibodies against cetuximab were found in pretreatment samples from 17 of these subjects; only 1 of 51 subjects who did not have a hypersensitivity reaction had such antibodies (P<0.001). IgE antibodies against cetuximab were found in 15 of 72 samples (20.8%) from control subjects in Tennessee, in 3 of 49 samples (6.1%) from northern California, and in 2 of 341 samples (0.6%) from Boston. The IgE antibodies were shown to be specific for an oligosaccharide, galactose-alpha-1,3-galactose, which is present on the Fab portion of the cetuximab heavy chain. CONCLUSIONS: In most subjects who had a hypersensitivity reaction to cetuximab, IgE antibodies against cetuximab were present in serum before therapy. The antibodies were specific for galactose-alpha-1,3-galactose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Humans also lack the ability to produce the Galα1–3Galβ1–4GlcNAc–R epitope, which is common in murine cells, and this has been shown to induce anaphylaxis [8,33].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Murine cells can also produce α-gal and Neu5Gc at considerably higher levels than hamster cells, increasing the risks of immunogenicity (Tangvoranuntakul et al., 2003;Chung et al., 2008;Macher and Galili, 2008;Padler-Karavani et al., 2008;Ghaderi et al., 2012).”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Chung et al., 2008
Experimental — accuracy not yet measuredIn the citing paper
“However, anti-α-Gal IgE antibodies can cause allergic reactions, such as anaphylaxis, against cetuximab, a therapeutic monoclonal antibody targeting epidermal growth factor receptor (EGFR)”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Chung et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Chung, K. Y., Shia, J., Kemeny, N. E., Shah, M., Schwartz, G. K., Tse, A., Hamilton, A., Pan, D., Schrag, D., Schwartz, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.037 · Cited by 1,081
(1945) · Harvard University Press eBooks · doi:10.4159/harvard.9780674184220 · Cited by 1,078
The diagnosis and management of anaphylaxis: An updated practice parameter
LIEBERMAN, P., KEMP, S., OPPENHEIMER, J., LANG, D., BERNSTEIN, I., NICKLAS, R., ANDERSON, J., BERNSTEIN, D., BERNSTEIN, J., & FINK, J. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.01.010 · Cited by 667
Symposium on the Definition and Management of Anaphylaxis: Summary report
Sampson, H. A., Muñoz-Furlong, A., Bock, S. A., Schmitt, C., Bass, R., Chowdhury, B. A., Decker, W. W., Furlong, T. J., Galli, S. J., Golden, D. B., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.01.009 · Cited by 641
The incidence and management of infusion reactions to infliximab: a large center experience
Cheifetz, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00231-4 · Cited by 491
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
Holgate, S., Casale, T., Wenzel, S., Bousquet, J., Deniz, Y., & Reisner, C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.053 · Cited by 466
Research works printed but not linked: 1
- Carolina; association with atopic history. J Clin Oncol 2007;25:3644-8.
Cited by
Items 801–900 of 1,002
Lakbub, J. C., Su, X., Zhu, Z., Patabandige, M. W., Hua, D., Go, E. P., & Desaire, H. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00289 · Cited by 13
Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.
Kuhlen, J. L., & Virkud, Y. V. (2015) · PubMed · Cited by 13
Red Meat Allergies after Lone Star Tick (Amblyomma americanum) Bites
Diaz, J. H. (2020) · Southern Medical Journal · doi:10.14423/smj.0000000000001102 · Cited by 13
Joral, A., Azketa, N., Sánchez, P., Vélez-del-Burgo, A., Aranzabal-Soto, M.-A., Lizarza, S., Martínez, J., & Postigo, I. (2022) · Foods · doi:10.3390/foods11030466 · Cited by 17
Ghahramani, G. K., & Temprano, J. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12672 · Cited by 13
Human IgE is efficiently produced in glycosylated and biologically active form in lepidopteran cells
Bantleon, F. I., Wolf, S., Seismann, H., Dam, S., Lorentzen, A. M., Miehe, M., Jabs, F., Jakob, T., Plum, M., & Spillner, E. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.02.013 · Cited by 13
Ikegawa, K., Suzuki, S., Nomura, H., Enokida, T., Yamazaki, T., Okano, S., Endo, K., Saito, S., Yamaguchi, M., & Tahara, M. (2017) · Journal of International Medical Research · doi:10.1177/0300060517713531 · Cited by 13
Alpha-Gal-assoziierte verzögerte Anaphylaxie gegen rotes Fleisch als Berufskrankheit
Anemüller, W., Mohr, M., Brans, R., Homann, A., & Jappe, U. (2018) · Der Hautarzt · doi:10.1007/s00105-018-4224-4 · Cited by 13
High incidence of cetuximab-related infusion reactions in head and neck patients
Coloma, V. P., Bravo, P. E., Lezghed, N., Mayache-Badis, L., Gómez, R. G. H., Iacob, M., Nicouleau, L., Desmaris, R., Tao, Y., Leibu, C., et al. (2018) · ESMO Open · doi:10.1136/esmoopen-2018-000346 · Cited by 13
Human Anti-Gal and Anti-Non-Gal Immune Response to Porcine Tissue Implants
Galili, U. (2015) · Host Response to Biomaterials · doi:10.1016/b978-0-12-800196-7.00010-4 · Cited by 12
Molecular basis for bacterial N-glycosylation by a soluble HMW1C-like N-glycosyltransferase
Piniello, B., Macías‐León, J., Miyazaki, S., García‐García, A., Compañón, I., Ghirardello, M., Taleb, V., Veloz, B., Corzana, F., Miyagawa, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41238-1 · Cited by 14
Saunders, M. N., Rival, C. M., Mandal, M., Cramton, K., Rad, L. M., Janczak, K. W., Williams, L. A., Angadi, A. R., O’Konek, J. J., Shea, L. D., et al. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2024.1437523 · Cited by 13
Jappe, U., Bergmann, K., Brinkmann, F., Faihs, V., Gülşen, A., Klimek, L., Renz, H., Seurig, S., Taube, C., Traidl, S., et al. (2024) · Allergologie select · doi:10.5414/alx02533e · Cited by 13
Shi, Y., Ba, Y., Wang, J., Xiong, J., Gu, K., Chen, Y., Zheng, Z., Wang, Z., Guo, W., Cheng, Y., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02229-4 · Cited by 12
Szekrényes, Á., Partyka, J., Váradi, C., Křenková, J., Foret, F., & Guttman, A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2353-3_16 · Cited by 12
Unambiguous identification of α-Gal epitopes in intact monoclonal antibodies by NMR spectroscopy
Hinterholzer, A., Moises, J. E., Regl, C., Schwap, S., Rapp, E., Huber, C. G., & Schubert, M. (2022) · mAbs · doi:10.1080/19420862.2022.2132977 · Cited by 14
Comprehensive N-Glycan Mapping using Parallel Reaction Monitoring LC–MS/MS
Shipman, J. J., Sommers, C. D., Keire, D. A., Chen, K., & Zhu, H. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03453-1 · Cited by 14
Food Allergies and Alpha-gal Syndrome for the Gastroenterologist
Lee, C., & McGill, S. (2023) · Current Gastroenterology Reports · doi:10.1007/s11894-022-00860-7 · Cited by 13
Hochrisikogruppen für eine Alpha-Gal-Sensibilisierung
Benders-Guedj, M., Köberle, M., Hofmann, H., Biedermann, T., & Darsow, U. G. (2023) · Allergologie · doi:10.5414/alx02424e · Cited by 12
Alpha‐gal syndrome—Food or drug allergy: A case report
Božan, M., Lazarević, V. V., Marković, I., Morović‐Vergles, J., & Mitrović, J. (2023) · Clinical Case Reports · doi:10.1002/ccr3.7830 · Cited by 12
Perioperative Considerations in Alpha-Gal Syndrome: A Review
Leder, J., Diederich, A., Patel, B., Bowie, M., Renwick, C. M., & Mangunta, V. R. (2024) · Cureus · doi:10.7759/cureus.53208 · Cited by 22
Selection of positive controls and their impact on anti-drug antibody assay performance
Weiner, J. A., Natarajan, H., McIntosh, C. J., Yang, E. S., Choe, M., Papia, C. L., Axelrod, K. S., Kovacikova, G., Pegu, A., & Ackerman, M. E. (2024) · Journal of Immunological Methods · doi:10.1016/j.jim.2024.113657 · Cited by 12
Application of Quality by Design Paradigm to the Manufacture of Protein Therapeutics
del Val, I. J., Philip, M., Exley, K., Sou, S. N., Kyriakopoulos, S., Polizzi, K. M., & Kontoravdi, C. (2012) · InTech eBooks · doi:10.5772/50261 · Cited by 17
Tep, S., Hincapie, M., & Hancock, W. S. (2011) · Carbohydrate Research · doi:10.1016/j.carres.2011.10.005 · Cited by 12
Challenges in Developing Antidrug Antibody Screening Assays
Dodge, R. W., Daus, C., & Yaskanin, D. D. (2009) · Bioanalysis · doi:10.4155/bio.09.55 · Cited by 12
Characterization of N-glycosylation and amino acid sequence features of immunoglobulins from swine
Lopez, P. G., Girard, L., Buist, M., de Oliveira, A. G. G., Bodnar, E. D., Salama, A., Soulillou, J., & Perreault, H. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9637-z · Cited by 13
Bupathi, M., Hajjar, J., Bean, S. A., Fu, S., Hong, D. S., Karp, D. D., Stephen, B., Hess, K. R., Meric‐Bernstam, F., & Naing, A. (2016) · Investigational New Drugs · doi:10.1007/s10637-016-0395-y · Cited by 14
Faraji, F., Karjoo, Z., Moghaddam, M. V., Heidari, S., Emameh, R. Z., & Falak, R. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2018.1471139 · Cited by 12
Hennicke, J., Schwaigerlehner, L., Grünwald‐Gruber, C., Bally, I., Ling, W. L., Thielens, N. M., Reiser, J., & Kunert, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229992 · Cited by 12
Immunotherapy-Related Publications in Colorectal Cancer: A Bibliometric Analysis
Sur, D. G., Lungulescu, C., Puscariu, I.-I., Volovăț, S. R., Preda, M., Mateianu, E. A., & Lungulescu, C. V. (2021) · Healthcare · doi:10.3390/healthcare10010075 · Cited by 13
Ribecco, A. S., Pino, M. S., Cipriani, G., Marinozzi, C., & Fioretto, L. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2013.837667 · Cited by 13
Nasal septum perforation and bevacizumab
Power, D. G., & Kemeny, N. E. (2010) · Medical Oncology · doi:10.1007/s12032-010-9464-9 · Cited by 12
Delayed red meat allergy: clinical ramifications of galactose-α-1,3-galactose sensitization
Stewart, P. H., McMullan, K. L., & LeBlanc, S. B. (2015) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2015.08.003 · Cited by 16
Yamada, H., Matsumura, C., Yamada, K., Teshima, K., Hiroshima, T., Kinoshita, M., Suzuki, S., & Kakehi, K. (2017) · Electrophoresis · doi:10.1002/elps.201700014 · Cited by 12
Through the barricades: overcoming the barriers to effective antibody-based cancer therapeutics
Dalziel, M., Beers, S. A., Cragg, M. S., & Crispin, M. (2018) · Glycobiology · doi:10.1093/glycob/cwy043 · Cited by 15
Cell Line Development for Therapeutic Protein Production
Noh, S. M., Shin, S., & Lee, G. M. (2019) · Wiley eBooks · doi:10.1002/9783527811410.ch2 · Cited by 16
Mites, ticks, anaphylaxis and allergy: The Acari hypothesis
Retzinger, A. C., & Retzinger, G. S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110257 · Cited by 12
Application of the Antibody-Inducing Activity of Glycosphingolipids to Human Diseases
OKUDA, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073776 · Cited by 12
Wen, S., Unuma, K., Chinuki, Y., Hikino, H., & Uemura, K. (2021) · Legal Medicine · doi:10.1016/j.legalmed.2021.101878 · Cited by 13
5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland
Beck, A., Reichert, J. M., & Wurch, T. (2010) · mAbs · doi:10.4161/mabs.2.2.11302 · Cited by 13
Temperature-induced unfolding, aggregation, and interaction of therapeutic monoclonal antibodies
Menzen, T. (2014) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.17520 · Cited by 19
A Review of Alpha-Gal Syndrome for the Infectious Diseases Practitioner
Shishido, A. A., & Wormser, G. P. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf430 · Cited by 14
Tummala, S. B., Titus, M., Lee, W., Wang, C., Ciatto, C., Thill, G., Foster, D. J., Li, C., Szabó, Z., Guttman, A., et al. (2013) · Biotechnology Progress · doi:10.1002/btpr.1667 · Cited by 12
Suddenly Steakless: A Gastroenterologist's Guide to Managing Alpha-Gal Allergy
McGill, S., Richards, R. D., & Commins, S. P. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001765 · Cited by 11
Torres, M. J., Labella, M., María, R. S. D. S., Bogas, G., Salas, M. L., Fernández, T. D., Mayorga, C., & Doña, I. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221024154951 · Cited by 12
Maldonado-Ruiz, L. P., Reif, K. E., Ghosh, A., Foré, S. A., Johnson, R. L., & Park, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-48437-2 · Cited by 12
Assessment of monoclonal antibody glycosylation: a comparative study using HRMS, NMR, and HILIC-FLD
Shipman, J. J., Karfunkle, M., Zhu, H., Zhuo, Y., Chen, K., Patabandige, M. W., Wu, D., Oyugi, M. A., Kerr, R., Yang, K., et al. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05261-5 · Cited by 13
Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro
Yi, C., Ruan, C., Wang, H., Xu, X., Zhao, Y., Fang, M., Ji, J., Gu, X., & Gao, C. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.77 · Cited by 13
Physicochemical and biological characterization of 1E10 Anti-Idiotype vaccine
Machado, Y. J., Rabasa, Y., Montesinos, R., Cremata, J. A., Besada, V., Fuentes, D., Castillo, A., de la Luz, K. R., Vázquez, A. M., & Himly, M. (2011) · BMC Biotechnology · doi:10.1186/1472-6750-11-112 · Cited by 11
New Trends in Epidermal Growth Factor Receptor-Directed Monoclonal Antibodies
Markman, B., Capdevila, J., Élez, E., & Tabernero, J. M. (2009) · Immunotherapy · doi:10.2217/imt.09.66 · Cited by 15
Tohnai, I., Umeda, M., Kirita, T., Yanamoto, S., Yamashita, T., Hiratsuka, H., Yokoo, S., Tanzawa, H., Uzawa, N., Shibahara, T., et al. (2016) · Journal of Japanese Society of Oral Oncology · doi:10.5843/jsot.28.169 · Cited by 11
Detection of Memory B Activity Against a Therapeutic Protein in Treatment-Naïve Subjects
Liao, K., Derbyshire, S., Wang, K.-F., Caucci, C., Tang, S., Holland, C., Loercher, A. E., & Gunn, G. R. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0198-5 · Cited by 11
Anaphylactic reactions to biological drugs
Matucci, A., Vultaggio, A., Nencini, F., & Maggi, E. (2020) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000666 · Cited by 11
Tick hypersensitivity and human tick‐borne diseases
Ng, Y. Q., Gupte, T. P., & Krause, P. J. (2021) · Parasite Immunology · doi:10.1111/pim.12819 · Cited by 11
Rosenberg, Y. J., Jiang, X., Mao, L., Hernandez, S., & Lee, K. (2012) · InTech eBooks · doi:10.5772/29014 · Cited by 11
Safety profile and practical considerations of monoclonal antibody treatment
Estruch, B. C. (2013) · Neurología (English Edition) · doi:10.1016/j.nrleng.2010.06.004 · Cited by 19
Slayden, T. A., Shakir, M. K. M., & Hoang, T. D. (2019) · AACE Clinical Case Reports · doi:10.4158/accr-2019-0495 · Cited by 11
Investigating the role of ERAD on antibody processing in glycoengineeredSaccharomyces cerevisiae
Piirainen, M. A., & Frey, A. D. (2020) · FEMS Yeast Research · doi:10.1093/femsyr/foaa002 · Cited by 13
GIANT URTICARIA AND PERSISTENT NEUTRALIZING ANTIBODIES AFTER THE FIRST NATALIZUMAB INFUSION
Cohen, M., Rocher, F., Vivinus, S., Thomas, P., & Lebrun‐Frénay, C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dad567 · Cited by 11
Pre-clinical strategies and emerging technologies driving advances in the alpha-gal syndrome
Erickson, L. D., Wilson, J. M., Cramton, K., & Rival, C. M. (2025) · Allergology International · doi:10.1016/j.alit.2025.03.004 · Cited by 10
Update on desensitization to chemotherapeutics and biologicals
Caiado, J., & Castells, M. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.07.018 · Cited by 10
Glycan Profiles of FDA-Approved Therapeutic Antibodies: Insights from Regulatory Submissions
Luo, S. Q., Hess, K., Rogstad, S., & Zhang, B. (2026) · The AAPS Journal · doi:10.1208/s12248-026-01207-0 · Cited by 10
Recent Advances in Glycosylation Modifications in the Context of Therapeutic Glycoproteins
Zhong, X., & Somers, W. (2012) · InTech eBooks · doi:10.5772/29708 · Cited by 11
Higel, F., Seidl, A., Demelbauer, U. M., Sörgel, F., & Frieß, W. (2014) · mAbs · doi:10.4161/mabs.29263 · Cited by 10
Chai, Y., Cao, X.-X., Ge, M.-M., Mi, C., Guo, X. H., & Wang, T. (2020) · Biochemical Engineering Journal · doi:10.1016/j.bej.2020.107663 · Cited by 11
Delayed Hypersensitivity Reaction to Infliximab Due to Mammalian Meat Allergy
Polanco, E. G., & Borowitz, S. M. (2023) · JPGN Reports · doi:10.1097/pg9.0000000000000322 · Cited by 10
Tick salivary glycans – a sugar-coated tick bite
Karim, S., Leyva-Castillo, J. M., & Narasimhan, S. (2023) · Trends in Parasitology · doi:10.1016/j.pt.2023.09.012 · Cited by 11
Glycosylation of recombinant adeno-associated virus serotype 6
Yamaguchi, Y., Ishii, K., Koizumi, S., Sakaue, H., Maruno, T., Fukuhara, M., Shibuya, R., Tsunaka, Y., Matsushita, A., Bandoh, K., et al. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101256 · Cited by 11
Wahoski, C. C., & Singh, B. (2024) · Cancers · doi:10.3390/cancers16132472 · Cited by 9
Glaser, T., Culbreth, R. E., Liebelt, E. L., Ruha, A., Greene, S. C., Campleman, S. L., Spyres, M. B., & On behalf of the ToxIC Snakebite Study Group (2025) · Journal of Medical Toxicology · doi:10.1007/s13181-025-01078-5 · Cited by 10
Recent Advances in Biotherapeutics Drug Discovery and Development
Zhong, X., Neumann, P. J., Corbo, M., & Loh, E. (2011) · InTech eBooks · doi:10.5772/28094 · Cited by 11
Patient considerations in metastatic colorectal cancer – role of panitumumab
Rogers, J. E. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s115430 · Cited by 10
Innovation in Cell Banking, Expansion, and Production Culture
Kshirsagar, R., & Ryll, T. (2018) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2016_56 · Cited by 11
Kim, J., Luo, H., White, W. I., Rees, W. A., Venkat, R. V., & Albarghouthi, M. N. (2020) · mAbs · doi:10.1080/19420862.2020.1844928 · Cited by 12
Trappe, A., Füssl, F., Millán‐Martín, S., Ronan, R., Zaborowska, I., & Bones, J. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123186 · Cited by 10
Lee, L. Y. G. N., Leow, S. Y., Wen, H., Soh, J. Y., Chiang, W. C., Zhong, Y., Tham, E. H., Loh, W., Delsing, D. J. M., Lee, B. W., et al. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.840454 · Cited by 10
The red meat allergy syndrome in Sweden
Apostolović, D., Tran, T. A. T., Starkhammar, M., Sánchez‐Vidaurre, S., Hamsten, C., & van Hage, M. (2016) · Allergo Journal · doi:10.1007/s15007-016-1044-7 · Cited by 10
Kreft, L., Schepers, A., Hils, M., Swiontek, K., Flatley, A., Janowski, R., Mirzaei, M. K., Dittmar, M., Chakrapani, N., Desai, M. S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958952 · Cited by 11
A Review of Adverse Reactions to Biologics Used in Allergy-Immunology Practice
Chow, T. G., Oppenheimer, J., & Joshi, S. R. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.09.020 · Cited by 10
Alpha-Gal Syndrome in the Infectious Diseases Clinic: A Series of 5 Cases in Central North Carolina
Boyce, R. M., Schulz, A., Mansour, O., Giandomenico, D., Farel, C. E., & Commins, S. P. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac663 · Cited by 11
Estruch, B. C. (2012) · Neurología · doi:10.1016/j.nrl.2011.02.004 · Cited by 12
Deciphering O-glycomics for the development and production of biopharmaceuticals
Zhang, P., Wang, T., Bardor, M., & Song, Z. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.7 · Cited by 10
Iberri, D. J., & Colevas, A. D. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0177 · Cited by 11
Immunogenicity Assessment of Biosimilars: A Multidisciplinary Perspective
Chamberlain, P., & Kurki, P. (2018) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-99680-6_19 · Cited by 10
Food allergy: what it is and what it is not?
Lin, C. H. (2018) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000506 · Cited by 11
Cid, E., Yamamoto, M., & Yamamoto, F. (2019) · Scientific Reports · doi:10.1038/s41598-018-37515-5 · Cited by 11
At-line high throughput site-specific glycan profiling using targeted mass spectrometry
Chi, B., Veyssier, C. S., Kasali, T., Uddin, F., & Sellick, C. A. (2020) · Biotechnology Reports · doi:10.1016/j.btre.2020.e00424 · Cited by 10
Analytical comparability assessment on glycosylation of ziv-aflibercept and the biosimilar candidate
Shen, Z., Wang, Y., Xu, H., Zhang, Q., Sha, C., Sun, B., & Li, Q. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.03.020 · Cited by 11
Serrier, J., Khoy, K., Ollivier, Y., Gervais, R., Moel, G. L., Lafosse, M., Johnson, A. C., Mauff, B. L., & Mariotte, D. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.02.013 · Cited by 10
Les allergènes moléculaires : évolution ou révolution dans le diagnostic de l’allergie
Bienvenu, J., Rouzaire, P., & Bienvenu, F. (2011) · Revue française d'allergologie · doi:10.1016/j.reval.2011.02.008 · Cited by 11
Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
Naseem, Z., Muhammad, A., Chatterjee, A. B., & Rubio‐Tapia, A. (2025) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.92a.24072 · Cited by 10
Cut Point in Immunogenicity Testing: A Flawed Concept We Can Live Without
Kubiak, R. J. (2025) · The AAPS Journal · doi:10.1208/s12248-025-01153-3 · Cited by 9
Murray, T. V., Kozakowska-McDonnell, K., Tibbles, A., Taylor, A. L., Higazi, D. R., Rossy, E., Rossi, A., Genapathy, S., Tamburrino, G., Rath, N., et al. (2021) · mAbs · doi:10.1080/19420862.2021.1992068 · Cited by 9
Tepetam, F. M., Katran, Z. Y., Barın, R. B., & Uğurlu, B. Ç. (2023) · Tuberkuloz ve Toraks · doi:10.5578/tt.20239714 · Cited by 9
Banner, W., Edelen, K. L., Epperson, L. C., & Moore, E. (2024) · Toxicology Communications · doi:10.1080/24734306.2024.2314314 · Cited by 9
Alpha-Gal Syndrome and Cardiac Surgery
Zvara, J., Smith, A. L., Mazzeffi, M. A., Kleiman, A. M., Tanaka, K. A., Smith, A. R., Wilson, J. M., & McNeil, J. S. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.07.035 · Cited by 9
Erkaya, D. G. U., Durmaz, M. S. B., Akın, B. G., & Bavbek, S. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.12397 · Cited by 10
Allergic hypersensitivity to red meat induced by tick bites: a French case report
Guillier, A., Fauconneau, A., Barruel, F. D., Guez, S., & Doutre, M. ‐. (2015) · European Journal of Dermatology · doi:10.1684/ejd.2015.2531 · Cited by 9
Reynard, O., Jacquot, F., Evanno, G., Mai, H. L., Salama, A., Martinet, B., Duvaux-Miret, O., Bach, J., Conchon, S., Judor, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156775 · Cited by 10
de Haan, N., Reiding, K. R., & Wuhrer, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6493-2_5 · Cited by 10
Metadata
- Authors
- Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., Slebos, R. J., Zhou, Q., Gold, D., Hatley, T., Hicklin, D. J., & Platts-Mills, T. A. E.
- Affiliations
- Vanderbilt University (US)
- Bristol-Myers Squibb (United States) (US)
- Stanford University (US)
- Duke Medical Center (US)
- University of Virginia (US)
- Harvard University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-03-13
- Volume
- 358
- Issue
- 11
- Pages
- 1109-1117
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2361129
- OpenAlex
- W2140035322
- Cited by
- 1,521
- References
- 35
- Citations by year
- 2026: 63 · 2025: 79 · 2024: 64 · 2023: 83 · 2022: 78 · 2021: 78 · 2020: 94 · 2019: 80 · 2018: 78 · 2017: 109 · 2016: 90 · 2015: 99 · 2014: 88 · 2013: 97 · 2012: 94
- FWCI
- 57.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- Bristol-Myers Squibb
- Vanderbilt University
- Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
- National Institutes of Health (20565, 2r01ai020565-29, 5r01ca118582-05, AI-20565)
- U.S. Public Health Service (AI-AADCRC-U19-070364)
- National Cancer Institute (R01-CA-118582, P50CA095103, P50CA95103)
- National Institute of Allergy and Infectious Diseases (AI 20565, R01AI035796, R01AI-020565, AI/EHS-35796, R29AI035796, R37AI020565)
- National Institute of Dental and Craniofacial Research (R01DE017982)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Keywords
- cetuximab, anaphylaxis, drug hypersensitivity, IgE antibodies, galactose-alpha-1,3-galactose, Fab fragment, monoclonal antibodies, epidermal growth factor receptor, pre-existing antibodies, colorectal cancer, head and neck squamous cell carcinoma
- MeSH terms
- Cetuximab, Adult, Aged, Aged, 80 and over, Anaphylaxis, Antibodies, Monoclonal, Epitopes, Antineoplastic Agents, Cross Reactions, Disaccharides, Female, Humans, Immunoglobulin E, Male, Middle Aged, Protein Binding, Protein Conformation, Case-Control Studies, Antibodies, Monoclonal, Humanized, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.